The AstraZeneca cancer drug spinoff floated above its range in an upsized initial public offering and now has a market cap topping $2bn.

NetEase, SoftBank, Time Warner, Madison Square Garden, Dick Clark Productions, Citic Guoan, Founder Group and Comcast have all exited the VR viewing platform at a reduced valuation.

Genscript Biotech’s subsidiary Legend Biotech, which agreed to an investment worth nearly $151m from Eli Lilly and Johnson & Johnson last month, has filed to go public.

Customer communications technology provider Kustomer has acquired chatbot developer Reply, handing exits to Aflac, R/GA and Westfield.

CyberArk has bought zero-trust identity management platform Idaptive for $70m in cash, two years after it was spun out from Centrify.

Slack-aligned online help desk tool provider Halp has been picked up by Atlassian after disclosing just $2.6m in funding.

The Johns Hopkins University-founded wound evaluation software developer had counted Tencent and Penn Medicine among its backers.

Qihoo 360-founded Qi An Xin has filed for an initial public offering on China’s Star Market that will provide exits for Red Star Macalline and China Electronics Corporation.

The JD.com and Walmart-backed company is expected to raise as much as $500m in proceeds when it lists on the Nasdaq Global Select Market.

Hua Insurance is in line for a bigger exit as Qingdao Victall Railway oversubscribes its planned initial public offering to raise as much as $172m in proceeds.